Paratek Pharma announces positive top-line data from phase 2b study of oral omadacycline in NTM abscessus pulmonary disease: Boston Monday, November 11, 2024, 18:00 Hrs [IST] Para ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback